- Home
- TRAK vs CMPX Comparison
TRAK vs CMPX Comparison
Compare TRAK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- CMPX
- Stock Information
- Founded
- TRAK 1990
- CMPX 2014
- Country
- TRAK United States
- CMPX United States
- Employees
- TRAK N/A
- CMPX N/A
- Industry
- TRAK EDP Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- TRAK Technology
- CMPX Health Care
- Exchange
- TRAK Nasdaq
- CMPX Nasdaq
- Market Cap
- TRAK 355.4M
- CMPX 408.6M
- IPO Year
- TRAK 1998
- CMPX N/A
- Fundamental
- Price
- TRAK $20.17
- CMPX $2.24
- Analyst Decision
- TRAK Strong Buy
- CMPX Strong Buy
- Analyst Count
- TRAK 1
- CMPX 7
- Target Price
- TRAK $24.00
- CMPX $12.43
- AVG Volume (30 Days)
- TRAK 51.2K
- CMPX 1.8M
- Earning Date
- TRAK 05-14-2025
- CMPX 05-12-2025
- Dividend Yield
- TRAK 0.36%
- CMPX N/A
- EPS Growth
- TRAK 14.28
- CMPX N/A
- EPS
- TRAK 0.32
- CMPX N/A
- Revenue
- TRAK $21,199,507.00
- CMPX $850,000.00
- Revenue This Year
- TRAK $15.61
- CMPX $47.65
- Revenue Next Year
- TRAK $15.00
- CMPX $3,909.48
- P/E Ratio
- TRAK $63.07
- CMPX N/A
- Revenue Growth
- TRAK 6.99
- CMPX N/A
- 52 Week Low
- TRAK $14.23
- CMPX $0.77
- 52 Week High
- TRAK $25.01
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- TRAK 47.73
- CMPX 44.45
- Support Level
- TRAK $19.75
- CMPX $2.18
- Resistance Level
- TRAK $20.99
- CMPX $2.17
- Average True Range (ATR)
- TRAK 0.61
- CMPX 0.22
- MACD
- TRAK 0.09
- CMPX -0.02
- Stochastic Oscillator
- TRAK 61.45
- CMPX 68.16
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.